Diversified Healthcare Trust (NASDAQ:DHC) Earns Buy Rating from Analysts at B. Riley

B. Riley started coverage on shares of Diversified Healthcare Trust (NASDAQ:DHC) in a report published on Thursday morning. The firm issued a buy rating and a $4.50 target price on the real estate investment trust’s stock.

Separately, StockNews.com raised Diversified Healthcare Trust from a “sell” rating to a “hold” rating in a research report on Tuesday, April 1st.

Diversified Healthcare Trust Price Performance

Diversified Healthcare Trust stock opened at $2.28 on Thursday. The company has a debt-to-equity ratio of 1.44, a current ratio of 11.57 and a quick ratio of 11.57. The stock has a market cap of $550.02 million, a price-to-earnings ratio of -1.42 and a beta of 2.02. The firm has a 50-day moving average of $2.57 and a two-hundred day moving average of $2.76. Diversified Healthcare Trust has a 1 year low of $2.01 and a 1 year high of $4.24.

Diversified Healthcare Trust (NASDAQ:DHC) last announced its quarterly earnings results on Tuesday, February 25th. The real estate investment trust reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.31. The firm had revenue of $379.62 million during the quarter, compared to analyst estimates of $370.97 million. Diversified Healthcare Trust had a negative return on equity of 17.55% and a negative net margin of 26.09%.

Diversified Healthcare Trust Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, February 20th. Shareholders of record on Monday, January 27th were given a dividend of $0.01 per share. The ex-dividend date of this dividend was Monday, January 27th. This represents a $0.04 annualized dividend and a yield of 1.75%. Diversified Healthcare Trust’s dividend payout ratio (DPR) is presently -2.60%.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Diversified Healthcare Trust by 41.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 384,477 shares of the real estate investment trust’s stock worth $884,000 after purchasing an additional 112,701 shares in the last quarter. Union Square Park Capital Management LLC grew its position in shares of Diversified Healthcare Trust by 32.1% in the 4th quarter. Union Square Park Capital Management LLC now owns 925,000 shares of the real estate investment trust’s stock worth $2,128,000 after buying an additional 225,000 shares during the last quarter. State of Wyoming raised its stake in shares of Diversified Healthcare Trust by 15.2% during the 4th quarter. State of Wyoming now owns 54,284 shares of the real estate investment trust’s stock worth $125,000 after acquiring an additional 7,175 shares in the last quarter. Southport Management L.L.C. lifted its position in Diversified Healthcare Trust by 20.0% during the fourth quarter. Southport Management L.L.C. now owns 90,000 shares of the real estate investment trust’s stock valued at $207,000 after acquiring an additional 15,000 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. lifted its position in Diversified Healthcare Trust by 133.1% during the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 44,864 shares of the real estate investment trust’s stock valued at $103,000 after acquiring an additional 25,614 shares during the last quarter. 75.98% of the stock is owned by institutional investors.

About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.